Susan Hasty, Publisher
Table of Contents . . . February 2nd, 1998Non-Subscriber - Summaries Only
Risk Factors (HGV) - Drinking, Transfusions Linked to Hepatitis G Infection
At-Risk Populations (HAV) - Outbreak Among Gay Australians Underscores Vaccination Need
Carcinogenesis - Senescent Human Protein May Explain HBV-Linked Cancer
Quality of Life (HCV) - "Asymptomatic Infection" May Be Misnomer in Hepatitis C
Therapy (HCV) - NS5A Mutation Doesn't Predict IFN Response in Children
Blood Banking (Hepatitis G Virus) - No HGV RNA Detected in Blood Used for Transfusion
Conference Announcement (Blood Banking) - Blood Safety Conference Scheduled for February 1998
Alternative Medicines - Herbalist's Plant Extract Improves Resistance to Hepatitis Virus
Hepatitis B (Clinical Trials) - Approval Received To Begin HBV Study for ZADAXIN Thymosin Alpha 1 in Japan
Hepatitis C - HCV Helicase Enzyme Three-Dimensional Structure Reported
Hepatitis C Therapies - Chronic HCV Therapy Receives FDA Priority Classification
Occupational Risk - Researchers Discuss Routine HAV Immunization for Workers Exposed to HCV
Pathogenesis (HGV/HIV) - "Hepatitis G Viremia in HIV Infection: A Favorable Prognostic Factor?"
At-Risk Populations (HCV) - "Epidemiology of Hepatitis C Virus Infection among Injecting Drug Users in Australia."
Autoimmune Hepatitis - "Genetic Distinctions Between Types 1 and 2 Autoimmune Hepatitis."
Hepatocellular Carcinoma - "Hepatocellular Carcinoma: From Gene to Public Health."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.